Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 158

1.

iNOS dependent and independent phases of lymph node expansion in mice with TNF-induced inflammatory-erosive arthritis.

Bell RD, Slattery PN, Wu EK, Xing L, Ritchlin CT, Schwarz EM.

Arthritis Res Ther. 2019 Nov 14;21(1):240. doi: 10.1186/s13075-019-2039-z.

2.

TNF-Induced Interstitial Lung Disease in a Murine Arthritis Model: Accumulation of Activated Monocytes, Conventional Dendritic Cells, and CD21+/CD23- B Cell Follicles Is Prevented with Anti-TNF Therapy.

Wu EK, Henkes ZI, McGowan B, Bell RD, Velez MJ, Livingstone AM, Ritchlin CT, Schwarz EM, Rahimi H.

J Immunol. 2019 Dec 1;203(11):2837-2849. doi: 10.4049/jimmunol.1900473. Epub 2019 Oct 28.

PMID:
31659014
3.

Selective Sexual Dimorphisms in Musculoskeletal and Cardiopulmonary Pathologic Manifestations and Mortality Incidence in the Tumor Necrosis Factor-Transgenic Mouse Model of Rheumatoid Arthritis.

Bell RD, Wu EK, Rudmann CA, Forney M, Kaiser CRW, Wood RW, Chakkalakal JV, Paris ND, Klose A, Xiao GQ, Rangel-Moreno J, Garcia-Hernandez ML, Ritchlin CT, Schwarz EM, Rahimi H.

Arthritis Rheumatol. 2019 Sep;71(9):1512-1523. doi: 10.1002/art.40903. Epub 2019 Jul 22.

PMID:
30969024
4.

Amino Acid Profile of Synovial Fluid Following Intra-articular Ankle Fracture.

Leimer EM, Tanenbaum LM, Nettles DL, Bell RD, Easley ME, Setton LA, Adams SB.

Foot Ankle Int. 2018 Oct;39(10):1169-1177. doi: 10.1177/1071100718786163. Epub 2018 Aug 15.

5.

Intra-articular clearance of labeled dextrans from naive and arthritic rat knee joints.

Mwangi TK, Berke IM, Nieves EH, Bell RD, Adams SB, Setton LA.

J Control Release. 2018 Aug 10;283:76-83. doi: 10.1016/j.jconrel.2018.05.029. Epub 2018 May 26.

6.

Inhibition of 2-AG hydrolysis differentially regulates blood brain barrier permeability after injury.

Piro JR, Suidan GL, Quan J, Pi Y, O'Neill SM, Ilardi M, Pozdnyakov N, Lanz TA, Xi H, Bell RD, Samad TA.

J Neuroinflammation. 2018 May 14;15(1):142. doi: 10.1186/s12974-018-1166-9.

7.

Abnormal clotting of the intrinsic/contact pathway in Alzheimer disease patients is related to cognitive ability.

Suidan GL, Singh PK, Patel-Hett S, Chen ZL, Volfson D, Yamamoto-Imoto H, Norris EH, Bell RD, Strickland S.

Blood Adv. 2018 May 8;2(9):954-963. doi: 10.1182/bloodadvances.2018017798.

8.

Targeting the gut microbiome to treat the osteoarthritis of obesity.

Schott EM, Farnsworth CW, Grier A, Lillis JA, Soniwala S, Dadourian GH, Bell RD, Doolittle ML, Villani DA, Awad H, Ketz JP, Kamal F, Ackert-Bicknell C, Ashton JM, Gill SR, Mooney RA, Zuscik MJ.

JCI Insight. 2018 Apr 19;3(8). pii: 95997. doi: 10.1172/jci.insight.95997. eCollection 2018 Apr 19.

9.

Targeting lymphatic function as a novel therapeutic intervention for rheumatoid arthritis.

Bouta EM, Bell RD, Rahimi H, Xing L, Wood RW, Bingham CO 3rd, Ritchlin CT, Schwarz EM.

Nat Rev Rheumatol. 2018 Feb;14(2):94-106. doi: 10.1038/nrrheum.2017.205. Epub 2018 Jan 11. Review.

10.

Longitudinal micro-CT as an outcome measure of interstitial lung disease in TNF-transgenic mice.

Bell RD, Rudmann C, Wood RW, Schwarz EM, Rahimi H.

PLoS One. 2018 Jan 10;13(1):e0190678. doi: 10.1371/journal.pone.0190678. eCollection 2018.

11.

Inflammatory Microenvironment Persists After Bone Healing in Intra-articular Ankle Fractures.

Adams SB, Leimer EM, Setton LA, Bell RD, Easley ME, Huebner JL, Stabler TV, Kraus VB, Olson SA, Nettles DL.

Foot Ankle Int. 2017 May;38(5):479-484. doi: 10.1177/1071100717690427. Epub 2017 Jan 31.

PMID:
28142266
12.

Lipid profile of human synovial fluid following intra-articular ankle fracture.

Leimer EM, Pappan KL, Nettles DL, Bell RD, Easley ME, Olson SA, Setton LA, Adams SB.

J Orthop Res. 2017 Mar;35(3):657-666. doi: 10.1002/jor.23217. Epub 2016 Mar 14.

13.
14.

Inflammatory Cytokines and Matrix Metalloproteinases in the Synovial Fluid After Intra-articular Ankle Fracture.

Adams SB, Setton LA, Bell RD, Easley ME, Huebner JL, Stabler T, Kraus VB, Leimer EM, Olson SA, Nettles DL.

Foot Ankle Int. 2015 Nov;36(11):1264-71. doi: 10.1177/1071100715611176. Epub 2015 Oct 8.

PMID:
26449389
15.

In vivo luminescent imaging of NF-κB activity and NF-κB-related serum cytokine levels predict pain sensitivities in a rodent model of peripheral neuropathy.

Bowles RD, Karikari IO, VanDerwerken DN, Sinclair MS, Bell RD, Riebe KJ, Huebner JL, Kraus VB, Sempowski GD, Setton LA.

Eur J Pain. 2016 Mar;20(3):365-76. doi: 10.1002/ejp.732. Epub 2015 May 29.

16.

GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration.

Winkler EA, Nishida Y, Sagare AP, Rege SV, Bell RD, Perlmutter D, Sengillo JD, Hillman S, Kong P, Nelson AR, Sullivan JS, Zhao Z, Meiselman HJ, Wendy RB, Soto J, Abel ED, Makshanoff J, Zuniga E, De Vivo DC, Zlokovic BV.

Nat Neurosci. 2015 Apr;18(4):521-530. doi: 10.1038/nn.3966. Epub 2015 Mar 2.

17.

Synthesis and characterization of silk fibroin microparticles for intra-articular drug delivery.

Mwangi TK, Bowles RD, Tainter DM, Bell RD, Kaplan DL, Setton LA.

Int J Pharm. 2015 May 15;485(1-2):7-14. doi: 10.1016/j.ijpharm.2015.02.059. Epub 2015 Feb 24.

18.

Molecular characterization of chordoma xenografts generated from a novel primary chordoma cell source and two chordoma cell lines.

Karikari IO, Gilchrist CL, Jing L, Alcorta DA, Chen J, Richardson WJ, Gabr MA, Bell RD, Kelley MJ, Bagley CA, Setton LA.

J Neurosurg Spine. 2014 Sep;21(3):386-93. doi: 10.3171/2014.4.SPINE13262. Epub 2014 Jun 6.

19.

Identification and initial functional characterization of a human vascular cell-enriched long noncoding RNA.

Bell RD, Long X, Lin M, Bergmann JH, Nanda V, Cowan SL, Zhou Q, Han Y, Spector DL, Zheng D, Miano JM.

Arterioscler Thromb Vasc Biol. 2014 Jun;34(6):1249-59. doi: 10.1161/ATVBAHA.114.303240. Epub 2014 Feb 27.

20.

In vivo luminescence imaging of NF-κB activity and serum cytokine levels predict pain sensitivities in a rodent model of osteoarthritis.

Bowles RD, Mata BA, Bell RD, Mwangi TK, Huebner JL, Kraus VB, Setton LA.

Arthritis Rheumatol. 2014 Mar;66(3):637-46. doi: 10.1002/art.38279.

21.

Novel partial anomalous pulmonary venous connection associated with brain abscess.

Koka A, Sachdev A, Yazbeck MF, Bell RD, Farrellc C.

J Clin Neurol. 2014 Jan;10(1):55-8. doi: 10.3988/jcn.2014.10.1.55. Epub 2014 Jan 6.

22.

Breaching the blood-brain barrier for drug delivery.

Bell RD, Ehlers MD.

Neuron. 2014 Jan 8;81(1):1-3. doi: 10.1016/j.neuron.2013.12.023.

23.

Pericyte loss influences Alzheimer-like neurodegeneration in mice.

Sagare AP, Bell RD, Zhao Z, Ma Q, Winkler EA, Ramanathan A, Zlokovic BV.

Nat Commun. 2013;4:2932. doi: 10.1038/ncomms3932.

24.

Low levels of copper disrupt brain amyloid-β homeostasis by altering its production and clearance.

Singh I, Sagare AP, Coma M, Perlmutter D, Gelein R, Bell RD, Deane RJ, Zhong E, Parisi M, Ciszewski J, Kasper RT, Deane R.

Proc Natl Acad Sci U S A. 2013 Sep 3;110(36):14771-6. doi: 10.1073/pnas.1302212110. Epub 2013 Aug 19.

25.

A lipoprotein receptor cluster IV mutant preferentially binds amyloid-β and regulates its clearance from the mouse brain.

Sagare AP, Bell RD, Srivastava A, Sengillo JD, Singh I, Nishida Y, Chow N, Zlokovic BV.

J Biol Chem. 2013 May 24;288(21):15154-66. doi: 10.1074/jbc.M112.439570. Epub 2013 Apr 11.

26.

An activated protein C analog stimulates neuronal production by human neural progenitor cells via a PAR1-PAR3-S1PR1-Akt pathway.

Guo H, Zhao Z, Yang Q, Wang M, Bell RD, Wang S, Chow N, Davis TP, Griffin JH, Goldman SA, Zlokovic BV.

J Neurosci. 2013 Apr 3;33(14):6181-90. doi: 10.1523/JNEUROSCI.4491-12.2013.

27.

Red blood cell transfusion increases the risk of thrombotic events in patients with subarachnoid hemorrhage.

Kumar MA, Boland TA, Baiou M, Moussouttas M, Herman JH, Bell RD, Rosenwasser RH, Kasner SE, Dechant VE.

Neurocrit Care. 2014 Feb;20(1):84-90. doi: 10.1007/s12028-013-9819-0.

PMID:
23423719
28.

Smooth muscle cell plasticity: fact or fiction?

Nguyen AT, Gomez D, Bell RD, Campbell JH, Clowes AW, Gabbiani G, Giachelli CM, Parmacek MS, Raines EW, Rusch NJ, Speer MY, Sturek M, Thyberg J, Towler DA, Weiser-Evans MC, Yan C, Miano JM, Owens GK.

Circ Res. 2013 Jan 4;112(1):17-22. doi: 10.1161/CIRCRESAHA.112.281048. Epub 2012 Oct 23. No abstract available.

29.

Neurovascular dysfunction and faulty amyloid β-peptide clearance in Alzheimer disease.

Sagare AP, Bell RD, Zlokovic BV.

Cold Spring Harb Perspect Med. 2012 Oct 1;2(10). pii: a011452. doi: 10.1101/cshperspect.a011452. Review.

30.
31.

Blood-spinal cord barrier pericyte reductions contribute to increased capillary permeability.

Winkler EA, Sengillo JD, Bell RD, Wang J, Zlokovic BV.

J Cereb Blood Flow Metab. 2012 Oct;32(10):1841-52. doi: 10.1038/jcbfm.2012.113. Epub 2012 Aug 1.

32.

The imbalance of vascular molecules in Alzheimer's disease.

Bell RD.

J Alzheimers Dis. 2012;32(3):699-709. doi: 10.3233/JAD-2012-121060. Review.

PMID:
22850315
33.

Neurovascular defects and faulty amyloid-β vascular clearance in Alzheimer's disease.

Sagare AP, Bell RD, Zlokovic BV.

J Alzheimers Dis. 2013;33 Suppl 1:S87-100. Review.

34.

Apolipoprotein E controls cerebrovascular integrity via cyclophilin A.

Bell RD, Winkler EA, Singh I, Sagare AP, Deane R, Wu Z, Holtzman DM, Betsholtz C, Armulik A, Sallstrom J, Berk BC, Zlokovic BV.

Nature. 2012 May 16;485(7399):512-6. doi: 10.1038/nature11087.

35.

Hypertension induces brain β-amyloid accumulation, cognitive impairment, and memory deterioration through activation of receptor for advanced glycation end products in brain vasculature.

Carnevale D, Mascio G, D'Andrea I, Fardella V, Bell RD, Branchi I, Pallante F, Zlokovic B, Yan SS, Lembo G.

Hypertension. 2012 Jul;60(1):188-97. doi: 10.1161/HYPERTENSIONAHA.112.195511. Epub 2012 May 21.

36.

A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease.

Deane R, Singh I, Sagare AP, Bell RD, Ross NT, LaRue B, Love R, Perry S, Paquette N, Deane RJ, Thiyagarajan M, Zarcone T, Fritz G, Friedman AE, Miller BL, Zlokovic BV.

J Clin Invest. 2012 Apr;122(4):1377-92. doi: 10.1172/JCI58642. Epub 2012 Mar 12.

37.

Central nervous system pericytes in health and disease.

Winkler EA, Bell RD, Zlokovic BV.

Nat Neurosci. 2011 Oct 26;14(11):1398-1405. doi: 10.1038/nn.2946.

38.

From the liver to the blood-brain barrier: an interconnected system regulating brain amyloid-β levels.

Sagare AP, Winkler EA, Bell RD, Deane R, Zlokovic BV.

J Neurosci Res. 2011 Jul;89(7):967-8. doi: 10.1002/jnr.22670. Epub 2011 Apr 19. No abstract available.

PMID:
21544850
39.

Medical school and residency influence on choice of an academic career and academic productivity among US neurology faculty.

Campbell PG, Lee YH, Bell RD, Maltenfort MG, Moshfeghi DM, Leng T, Moshfeghi AA, Ratliff JK.

Arch Neurol. 2011 Aug;68(8):999-1004. doi: 10.1001/archneurol.2011.67. Epub 2011 Apr 11.

PMID:
21482917
40.

Lack of Smad or Notch leads to a fatal game of brain pericyte hopscotch.

Winkler EA, Bell RD, Zlokovic BV.

Dev Cell. 2011 Mar 15;20(3):279-80. doi: 10.1016/j.devcel.2011.03.002.

41.

Protein S protects neurons from excitotoxic injury by activating the TAM receptor Tyro3-phosphatidylinositol 3-kinase-Akt pathway through its sex hormone-binding globulin-like region.

Zhong Z, Wang Y, Guo H, Sagare A, Fernández JA, Bell RD, Barrett TM, Griffin JH, Freeman RS, Zlokovic BV.

J Neurosci. 2010 Nov 17;30(46):15521-34. doi: 10.1523/JNEUROSCI.4437-10.2010.

42.

Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging.

Bell RD, Winkler EA, Sagare AP, Singh I, LaRue B, Deane R, Zlokovic BV.

Neuron. 2010 Nov 4;68(3):409-27. doi: 10.1016/j.neuron.2010.09.043.

43.

Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer's amyloid β-peptide elimination from the brain.

Zlokovic BV, Deane R, Sagare AP, Bell RD, Winkler EA.

J Neurochem. 2010 Dec;115(5):1077-89. doi: 10.1111/j.1471-4159.2010.07002.x. Epub 2010 Oct 5. Review.

44.

Pericyte-specific expression of PDGF beta receptor in mouse models with normal and deficient PDGF beta receptor signaling.

Winkler EA, Bell RD, Zlokovic BV.

Mol Neurodegener. 2010 Aug 25;5:32. doi: 10.1186/1750-1326-5-32.

45.

Protein S controls hypoxic/ischemic blood-brain barrier disruption through the TAM receptor Tyro3 and sphingosine 1-phosphate receptor.

Zhu D, Wang Y, Singh I, Bell RD, Deane R, Zhong Z, Sagare A, Winkler EA, Zlokovic BV.

Blood. 2010 Jun 10;115(23):4963-72. doi: 10.1182/blood-2010-01-262386. Epub 2010 Mar 26.

46.

Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.

Bell RD, Zlokovic BV.

Acta Neuropathol. 2009 Jul;118(1):103-13. doi: 10.1007/s00401-009-0522-3. Epub 2009 Mar 25. Review.

47.

Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease.

Deane R, Bell RD, Sagare A, Zlokovic BV.

CNS Neurol Disord Drug Targets. 2009 Mar;8(1):16-30. Review.

48.

SRF and myocardin regulate LRP-mediated amyloid-beta clearance in brain vascular cells.

Bell RD, Deane R, Chow N, Long X, Sagare A, Singh I, Streb JW, Guo H, Rubio A, Van Nostrand W, Miano JM, Zlokovic BV.

Nat Cell Biol. 2009 Feb;11(2):143-53. doi: 10.1038/ncb1819. Epub 2008 Dec 21.

49.

Myocardin is sufficient for a smooth muscle-like contractile phenotype.

Long X, Bell RD, Gerthoffer WT, Zlokovic BV, Miano JM.

Arterioscler Thromb Vasc Biol. 2008 Aug;28(8):1505-10. doi: 10.1161/ATVBAHA.108.166066. Epub 2008 May 1.

50.

Effectiveness of Factor IX complex concentrate in reversing warfarin associated coagulopathy for intracerebral hemorrhage.

Siddiq F, Jalil A, McDaniel C, Brock DG, Pineda CC, Bell RD, Lee K.

Neurocrit Care. 2008;8(1):36-41.

PMID:
17898941

Supplemental Content

Support Center